Immunology
NEC joins €6.5m European project using AI for pandemic vaccine design
November 6, 2026EU, Immunology, Infections and infestations, Pharmacy, Vaccine, collaboration, pandemic
NEC OncoImmunity, a subsidiary of NEC Corporation, is leading the AI-powered antigen prediction and vaccine design work in a four-year …
Charity commits £800,000 to AI research into late breast cancer recurrence
October 28, 2026AI, Immunology, Oncology, breast cancer, cytology, oncology, research and development
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026ADCs, Corporate, HPLC, Immunology, Infections and infestations, Oncology, manufacturing
Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing capacity and …
Trio become latest Symbiosis commercial additions
October 12, 2026CDMO, Devices, Diagnostics, Immunology, clinical trials, pharmaceutical markets
Symbiosis Pharmaceutical Services has further strengthened its commercial team with three new appointments. Payal Roychoudhury and JoaquÃn Pérez Fornieles join …
UK immunoglobulin supply faces growing pressure, report warns
October 12, 2026Manufacturing and Production Critical supplies, Immunology, NHS Blood and Transplant, Neurology, procurement
The UK may face increasing pressure to secure long-term supplies of immunoglobulin (Ig), with rising demand and heavy reliance on …
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
September 5, 2026Clinical & Scientific, Clinical Research, Clinical Trial Services, Clinical research Training, Clinical trial specialist packaging, Data Capture Asthma & COPD, Chronic Diseases, Immunology, Rare Diseases, Sample integrity, clinical trials, enrolment
By Dr. Richard Graham Industry conversations about clinical trial participation tend to focus on awareness, access, and willingness to enrol. …
AI in pharma: From lab development to patient impact
September 5, 2026AI, Cancer, Immunology, Merck, Vaccine, Virology, personalised medicine, pharma
In the decade to 2025, AI use in vaccine development has increased markedly but is the boom in research translating …
Mavatar announces research collaboration with Sobi
January 6, 2026Research and Development Immunology, Mavatar, Rare Diseases, sobi
Mavatar has announced the initiation of a non-clinical research collaboration with Sobi, using Mavatar’s technology to generate data insights into …
STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases
December 18, 2025Research and Development Bio-Thera, Immunology, Stada
STADA and Bio-Thera’s Gotenfia (golimumab), a biosimilar of Janssen’s Simponi, has received a positive opinion from the European Medicines Agency …
Celltrion’s Remsima IV approved by EC in liquid form
November 27, 2025Research and Development Celltrion Inc, Immunology
Celltrion’s Remsima IV, the first-ever liquid formulation of infliximab for autoimmune diseases, has been approved by the European Commission (EC). …
Alvotech biosimilar receives EC marketing approval
November 26, 2025Research and Development Alvotech, Immunology, Inflammatory disease, Rheumatology
The European Commission (EC) has granted marketing authorisation for Gobivaz, Alvotech’s first-in-market biosimilar of Simponi (golimumab), which is used for …
Chronic spontaneous urticaria – the impact on patient quality of life, ongoing developments in treatments and the importance of greater awareness
October 3, 2025Medical Communications, Research and Development Dermatology, Immunology, acute urticaria, chronic spontaneous urticaria, dermatology, immunology
The current forms of immunotherapy, how T cell therapy works and what the future holds
Neogap Therapeutics appoints Jonas Mattson to its board of directors
August 26, 2025Research and Development Corporate, Immunology, Neogap Therapeutics, Oncology, board of directors
Swedish biotech, Neogap Therapeutics, has appointed Jonas Mattson, an authority in cell therapy, to its board of directors. His appointment …
NICE recommends Benralizumab for Rare Form of Vasculitis
August 15, 2025Medical Communications, Research and Development AstraZeneca, Immunology, National Institute for Health and Care Excellence, vasculitis
The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s benralizumab (Fasenra) as an add-on treatment for adult …
Novartis candidate for Sjögren’s disease presents positive results
August 15, 2025Research and Development Immunology, Novartis, Sjögren’s disease, US Food and Drug Administration, clinical trial
Novartis has reported positive results from two phase 3 clinical trials – NEPTUNUS-1 and NEPTUNUS-2 – evaluating ianalumab in adults …
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
